• Fasenra: Double Action for EGPA

    EGPA now has a second treatment! Fasenra was approved in the fall of 2024 for EGPA and brings a new take on addressing the issues. Join this livestream to learn about the dual impact: IL-5 unique action and activating natural killer cells. 

  • Decision Tree: Best Practice For Care

    Figuring out how to navigate the complex health care system can be maddening. Join us to learn about a tool that will help you find the care you need and […]

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.